Sandoval-Sus, J. D., Hosein, P. J., Goodman, D., Stefanovic, A., Rosenblatt, J. D., & Lossos, I. S. (2012). Updated Analysis of a Prospective Phase II Trial of R-MACLO-IVAM Followed by Maintenance for Mantle Cell Lymphoma. In Blood (Vol. 120, pp. 1622–1622). American Society of Hematology. https://doi.org/10.1182/blood.v120.21.1622.1622

Sandoval-Sus, Jose D., Peter J. Hosein, Deborah Goodman, Alexandra Stefanovic, Joseph D. Rosenblatt, and Izidore S. Lossos. “Updated Analysis of a Prospective Phase II Trial of R-MACLO-IVAM Followed by Maintenance for Mantle Cell Lymphoma.” In Blood, 120:1622–1622. American Society of Hematology, 2012. https://doi.org/10.1182/blood.v120.21.1622.1622.

Sandoval-Sus JD, Hosein PJ, Goodman D, Stefanovic A, Rosenblatt JD, Lossos IS. Updated Analysis of a Prospective Phase II Trial of R-MACLO-IVAM Followed by Maintenance for Mantle Cell Lymphoma. In: Blood. American Society of Hematology; 2012. p. 1622–1622.

Sandoval-Sus, Jose D., et al. “Updated Analysis of a Prospective Phase II Trial of R-MACLO-IVAM Followed by Maintenance for Mantle Cell Lymphoma.” Blood, vol. 120, no. 21, American Society of Hematology, 2012, pp. 1622–1622. Crossref, doi:10.1182/blood.v120.21.1622.1622.

Sandoval-Sus JD, Hosein PJ, Goodman D, Stefanovic A, Rosenblatt JD, Lossos IS. Updated Analysis of a Prospective Phase II Trial of R-MACLO-IVAM Followed by Maintenance for Mantle Cell Lymphoma. Blood. American Society of Hematology; 2012. p. 1622–1622.